Evidence map›Paper›PMID 33548891›Full record

ArticleClinical imaging2021

COVID-19 vaccine is here: practical considerations for clinical imaging applications.

Sanaz Katal, Arshia Pouraryan, Ali Gholamrezanezhad

Open access · bronzeAbstract readEditorial
In one paragraph

Article in Clinical imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Article
  8. COVID-19 vaccination may cause FDG uptake beyond axillary area.European journal of hybrid imaging · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sanaz Katal
Arshia PouraryanUniversity of California, Davis. Electronic address: aapouraryan@ucdavis.edu.
Ali GholamrezanezhadKeck School of Medicine, University of Southern California (USC), Los Angles, CA, USA. Electronic address: ali.gholamrezanezhad@med.usc.edu.
University of California, Davis · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imaging tools are potentially able to provide valuable data regarding the development of an efficient vaccine against viral diseases. Tracking immune cells in vivo by imaging modalities can help us understand the intrinsic behaviors of immune cells in response to vaccine components. Imaging patterns at the vaccination site and draining lymph nodes might provide useful information about the vaccine potency. Besides, serial lung CT imaging has been purposed to evaluate vaccine efficiency regarding its protection against typical lung lesions of viral pneumonias. On the other hand, vaccination causes various confusing radiologic patterns that pose diagnostic challenges for clinicians and pitfalls for reading radiologists. This manuscript reviews potential applications of imaging modalities in the process of vaccine development and also goes over some of the imaging findings/pitfalls following vaccination.

Indexed as

COVID-19COVID-19 VaccinesHumansMagnetic Resonance ImagingRadiologistsSARS-CoV-2Tomography, X-Ray ComputedCOVID-19 VaccinesComputed tomography (CT)COVID-19ImagingImmune cellsImmunizationLymph node activationMagnetic resonance imaging (MRI)Positron emission tomography (PET)SARS-CoV-2Single-photon emission computed tomography (SPECT)Vaccination

Identifiers

PMID33548891
PMCPMC7842197
OpenAlexW3126475069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.